CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 200 enrolled
Drug / intervention
RhinoChill +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00808236
NCT00808236N/ACompleted
CompareCT.gov

Trans-Nasal Cooling With the RhinoChill Device Following Cardiac Arrest: A Pilot Study

BeneChill, Inc·interventional·Posted Dec 15, 2008·Updated Jun 10, 2011

In Brief

A clinical study evaluating RhinoChill and Control for Cardiac Arrest. Completed, enrolled 200 participants across 15 sites in 5 countries.

Detailed Summary

The purpose of the study was to demonstrate the safety and feasibility of early intranasal cooling prior to return of spontaneous circulation (ROSC) in the emergency medical services (EMS) environment. It was hypothesized that cooling during the resuscitation attempt would increase ROSC and subsequent survival. The study was not powered to demonstrate statistically-significant differences in any outcome parameter, but was intended as an exploratory study only.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCardiac Arrest
CountriesBelgium, Czechia, Germany, Italy, Sweden
Collaborators--

Timeline

N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedDec 15, 2008
Enrollment StartNov 1, 2008
Primary CompletionJun 1, 2009
Study CompletionSep 1, 2009
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 17.5 years ago

Interventions

RhinoChilldevice

Nasal catheters are placed and cooling is begun during the resuscitation attempt

Controlother

Advanced cardiac life support according to American Heart Association \& European Resuscitation Council 2005 Guidelines